Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin/Sulbactam (2:1) in Acute Bacterial Infections
NCT01760109Phase 4Completed
- Sponsor
- Xiangbei Welman Pharmaceuticals
- Start
- Jul 2011
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of piperacillin sodium + sulbactam sodium in respiratory tract infection (RTI), urinary tract infection (UTI), sponsored by Xiangbei Welman Pharmaceuticals. Started Jul 2011; status: completed.
02
Drugs
piperacillin sodium + sulbactam sodium
03
Conditions
respiratory tract infection (RTI)urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT01760109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01760109.